Romiplostim N01 accelerates platelet engraftment in autologousstem cell transplantation using non-cryopreserved peripheral blood stem cells for plasma cell neoplasms. [PDF]
Sheng X +10 more
europepmc +1 more source
Autologous and heterologous blood transfusion in head and neck cancer surgery.
OBJECTIVE: To determine if the use of autologous blood ameliorates the increased risk for cancer recurrence that has been associated with perioperative blood transfusion. DESIGN: Retrospective medical record review.
Terris, D J +3 more
core
British Journal of Haematology, Volume 208, Issue 6, Page 2288-2292, June 2026.
Takaaki Ono +9 more
wiley +1 more source
Association of red blood cell transfusions with periventricular leukomalacia in very preterm infants
Abstract Background and Objectives Red blood cell (RBC) transfusions have been associated with retinopathy of prematurity (ROP) and adverse longāterm neurodevelopmental outcomes in very preterm infants. Although lower transfusion thresholds reduce the incidence of ROP, they have not improved neurological outcome. Periventricular leukomalacia (PVL) is a
Thomas Brune +2 more
wiley +1 more source
Patient blood management and surgery: Impact of new surgical techniques on transfusion needs. [PDF]
Ansart F, Pirenne F.
europepmc +1 more source
Excessive intraoperative hemorrhage during orthognathic surgery in a patient with neurofibromatosis type 1: a case report and literature review. [PDF]
Sasahara N +5 more
europepmc +1 more source
Perioperative tranexamic acid in abdominally based free-flap breast reconstruction: A single-surgeon retrospective series. [PDF]
Ahdoot AI +4 more
europepmc +1 more source
Adjuvant Autologous Platelet-Rich Plasma Gel for Decreasing Blood Loss in Posterior Placenta Previa: A Case Series and Literature Review. [PDF]
Duangkum C +5 more
europepmc +1 more source
Serum Eye Drops: Implementation, Upscaling, and Patient-Centered Care - Insights from a Blood Bank in Western Austria. [PDF]
Siller A, Schennach H, Amato M.
europepmc +1 more source
Extreme Hyperhemolysis Syndrome in a Patient With Sickle Cell Disease Successfully Managed With Eculizumab: A Case of Survival at 1.2 g/dL Hemoglobin. [PDF]
Cordeiro I +4 more
europepmc +1 more source

